RxDoctor Payments Data

Jennifer Rossi

Nurse Practitioner · Tupelo, MSNPI 1184208449

Payments from drug & device makers

$3,324in general payments, 2019–2025

Across 220 payments — averaging $15.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$898
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$761
  • Lundbeck LLC$712
  • AbbVie$331
  • Neurocrine Biosciences, Inc.$265
  • Alkermes, Inc.$164
  • plus $195 from 7 others

What the payments were for

  • Food & beverage$3,22597%
  • Education$993%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,324 in reported general payments places this provider in the 90th percentile of 1,090 nurse practitioner providers in Mississippi.

See all nurse practitioner providers in Mississippi

Medicare billing

Part B allowed, 2024
$11,292
Medicare patients
63
Services billed
145

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate143$424,280
IngrezzaValbenazine Tosylate11$84,826
RexultiBrexpiprazole31$56,388
TrintellixVortioxetine Hydrobromide60$53,090
VraylarCariprazine Hcl31$45,830
Abilify MaintenaAripiprazole16$44,350
Risperdal ConstaRisperidone Microspheres12$28,810
Ziprasidone Hcl63$6,778
Lurasidone Hcl50$6,240
Quetiapine Fumarate328$5,714
Asenapine Maleate31$5,702
Aripiprazole196$5,606
FetzimaLevomilnacipran Hcl11$5,187
Olanzapine192$4,163
Buspirone Hcl219$3,900

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna, Risperdal Consta$898$453,090155 claims
Otsuka America Pharmaceutical, Inc.Rexulti, Abilify Maintena$69$100,73847 claims
Neurocrine Biosciences, Inc.Ingrezza$265$84,82611 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$13$53,09060 claims
AbbVieVraylar, Fetzima$331$51,01742 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,090 nurse practitioner providers in Mississippi.

Other nurse practitioner in Tupelo

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →